Targeting Neuroinflammation to Modulate Reactive Astrocytes for Treatment of Neurodegenerative Disease
Time: 11:40 am
day: Clinical & Commercial Track Day 2 AM
Details:
- Understanding the impact of astrocyte activation and the role of SEMA4D
- Exploring plasma GFAP as a biomarker of neuroinflammation
- The effect of blocking the upregulation of SEMA4D, preventing neuronal stress and cognitive decline
